| Related fucntions with liver diseases | Ref. | Association with liver cancer | Ref. | ||
| Ligands | Jagged1 | mutation: Alagille syndrome | [31] | upregulation: cancer, poor prognosis | [65] |
| copy number gain: cancer, poor prognosis | [57] | ||||
| Jagged2 | NR | NR | |||
| DLL1 | NR | NR | |||
| DLL3 | NR | NR | |||
| DLL4 | fibrosis and NASH pathogenesis | [52] | HBV-x relation | [90] | |
| Receptors | Notch1 | biliary differentiation from HPCs by autophagy | [77] | upregulation: cancer, poor prognosis | [78] |
| HBV-x relation | [90] | ||||
| Notch2 | bile duct development | [80] | aggressiveness of liver cancer | [79] | |
| relation with hepatoblastoma | [82] | HPCs: dedifferentiated liver cancer | [81] | ||
| genomic abnormality: Alagille syndrome | [34] | ||||
| Notch3 | diffentiation and progression of cholangiocarcinoma | [83] | HBV-x relation | [90] | |
| modulating the stemness of tumor cells | [84] | ||||
| Notch4 | hepatocytic-liniage commitment of HPCs | [87] | upregulation: cancer, poor prognosis | [88] | |
| HBV-x relation | [90] | ||||
NR: not definitely reported; HPCs: hepatocyte progenitor cells; NASH: nonalcoholic steatohepatitis.